News for '-thyrocare'

What are the Most Awaited IPOs of 2026?

What are the Most Awaited IPOs of 2026?

Rediff.com29 Oct 2025

Several companies across sectors like finance, healthcare, wellness, retail technology, and asset management are bracing up to hit the D-street. With an unprecedented 1.7 lakh crore raised in 2025, the momentum is likely to sustain in 2026.

Why Thyrocare sold out to PharmEasy

Why Thyrocare sold out to PharmEasy

Rediff.com5 Jul 2021

'I have done enough work for many years.' 'This is a decision that many people at my age need to review.' 'I may become an exit example for people to study.'

Amazon's entry into healthcare a headwind but diagnostic stocks attractive

Amazon's entry into healthcare a headwind but diagnostic stocks attractive

Rediff.com2 Jul 2025

The news that Amazon India has launched diagnostic services in select metro cities in partnership with the unlisted Orange Health Labs has led to a look at the competitive intensity in healthcare services. Listed companies in the space such as Dr Lal Path Labs, Metropolis Health, Thyrocare, Vijaya, and Krsnaa have all seen double-digit stock price corrections over the last 6-9 months.

Amazon enters India's $15 bn diagnostics market with At-Home testing

Amazon enters India's $15 bn diagnostics market with At-Home testing

Rediff.com23 Jun 2025

Amazon India has launched Amazon Diagnostics, an at-home healthcare service that allows customers to book lab tests, schedule appointments and receive digital reports directly via the Amazon app. Initially available in six cities-Bengaluru, Delhi, Gurgaon, Noida, Mumbai and Hyderabad-the service covers more than 450 PIN codes and offers access to over 800 diagnostic tests.

Half of India Faces Glucose Imbalance

Half of India Faces Glucose Imbalance

Rediff.com5 Dec 2024

'Obesity, especially central obesity and increased visceral fat due to physical inactivity, along with the consumption of high-calorie, high-fat, and high-sugar diets, are major contributing factors.'

COVID-19 test: Why patients opt out of private labs

COVID-19 test: Why patients opt out of private labs

Rediff.com27 Mar 2020

At present, the cost of testing for COVID-19 is Rs 4,500 per examination and the results are available within 24 hours. Almost 90 per cent of queries fizzle out after patients realise the cost of testing will not be borne by the government.

3 Pilots Tested Positive For Psychotropic Substances

3 Pilots Tested Positive For Psychotropic Substances

Rediff.com27 Aug 2022

commercial airlines and air navigation service providers have to carry out random drug tests on at least 10 per cent of their flight crew and air traffic controllers every year.

COVID-19 second wave: Delays in RT-PCR tests

COVID-19 second wave: Delays in RT-PCR tests

Rediff.com9 May 2021

While there is a shortage of testing kits, manpower and capacities, India does not have other scalable testing options.

Stool sampling among Covid-19 test options before govt

Stool sampling among Covid-19 test options before govt

Rediff.com18 Apr 2020

Private diagnostic laboratories have already approached the respective state governments and the municipalities where they are operating to approve protocols for such testing in clusters, reports Sohini Das.

4 IPOs to watch out for in 2022

4 IPOs to watch out for in 2022

Rediff.com22 Mar 2022

Once stability returns to the secondary market, companies that have obtained approval from Sebi will start tapping the market.

Explained: Dharavi's COVID-19 Success

Explained: Dharavi's COVID-19 Success

Rediff.com17 Jul 2020

Prasanna D Zore/Rediff.com reveals how the BMC has contained the spread of COVID-19 in Dharavi, India's largest slum, which WHO wants to know more about.

Labs bet on Covid tests for next growth phase

Labs bet on Covid tests for next growth phase

Rediff.com14 Sep 2020

The bouquet of Covid-19 tests that most diagnostic labs are offering include antibody tests (blood tests), rapid antigen tests (point of care tests that detect the presence of an antigen from a nasal or throat swab in case of SARS-CoV-2), and reverse transcription-polymerase chain reaction (RT-PCR) tests.

India readies for massive testing exercise after lockdown

India readies for massive testing exercise after lockdown

Rediff.com28 Mar 2020

The ICMR is working on a war footing to develop the testing ecosystem -- especially for the screening blood tests. NIV, Pune, is in the process of validating antibody-based screening kits.

Ban on private labs in Mumbai may hit COVID-19 battle

Ban on private labs in Mumbai may hit COVID-19 battle

Rediff.com13 Jun 2020

The testing rate is likely to slow down, report Pavan Lall and Sohini Das.

Labs say capping RT-PCR rates is big blow to business

Labs say capping RT-PCR rates is big blow to business

Rediff.com3 Apr 2021

'We urge the government to have discussions with private labs on the actual cost of running a test.'

Demand for Covid-19 tests growing 100 pc week-on-week

Demand for Covid-19 tests growing 100 pc week-on-week

Rediff.com23 Apr 2021

One challenge for many laboratories in ramping up is the shortage of trained manpower for collecting samples, report Sohini Das, Vinay Umarji and Virendra Singh Rawat.

From 2 lakhs to 3,300 crores! How A Velumani did it!

From 2 lakhs to 3,300 crores! How A Velumani did it!

Rediff.com8 Jun 2016

Thyrocare founder Arokiaswamy Velumani shares his success story with Anjuli Bhargava as he remembers the one person who stood by him through it all.

Can pvt labs do COVID-19 tests for free?

Can pvt labs do COVID-19 tests for free?

Rediff.com10 Apr 2020

'If the government doesn't subsidise, it would be a huge setback in the fight against COVID-19'

What exactly does a thyroid do?

What exactly does a thyroid do?

Rediff.com8 Mar 2007

Is the thyroid a disease? No. And here's what you also need to know.

ASK AJIT: Stocks To Buy, Sell, Hold

ASK AJIT: Stocks To Buy, Sell, Hold

Rediff.com24 Jan 2022

Ajit Mishra, vice president, research, Religare Broking, answers your queries.

COVID-19: Lessons to be learnt from Delhi, Mumbai

COVID-19: Lessons to be learnt from Delhi, Mumbai

Rediff.com27 Jul 2020

The two cities finally got their act together by ramping up the testing capacity and implementing stricter quarantine norms.

Stocks You Must AVOID or EXIT

Stocks You Must AVOID or EXIT

Rediff.com26 Apr 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Tata fosters another startup, invests in fitness co GOQii

Tata fosters another startup, invests in fitness co GOQii

Rediff.com3 Oct 2016

The company, which is a leading player in the Indian wearables market, is backed by angel investors like Shriram Nene and his wife and Bollywood actress Madhuri Dixit Nene and WhatApp's Neeraj Arora

Unfazed by legal blocks, Netmeds bets big on digital

Unfazed by legal blocks, Netmeds bets big on digital

Rediff.com8 Feb 2019

Netmeds is looking at using new technologies such as deep learning and data analytics to improve forecasting in terms of the demand of the products for pharma companies, reports Peerzada Abrar.

All you need to know about COVID-19 testing

All you need to know about COVID-19 testing

Rediff.com14 Apr 2020

Two kinds of diagnostic tests are being currently used in India -- RT-PCR test and rapid antibodies test -- as per the global health norms.

Is 'localised' herd immunity behind dip in India's Covid count?

Is 'localised' herd immunity behind dip in India's Covid count?

Rediff.com5 Jan 2021

While there is a glimmer of hope and India's COVID-19 numbers are on a definite decline for a combination of reasons, a vaccination programme continues to be important, particularly given the presence of a mutant, more transmissible strain, several experts said while cautioning against infection upticks ahead.

Over 70% newly-listed cos give smart returns to investors

Over 70% newly-listed cos give smart returns to investors

Rediff.com13 Sep 2016

Among the gainers, microfinance player Ujjivan Financial Services which made its stock market debut in May has seen the biggest rally in its share price.

Do you own these stocks? EXIT them NOW

Do you own these stocks? EXIT them NOW

Rediff.com22 Sep 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Special offers for NRIs from ICICI Bank

Special offers for NRIs from ICICI Bank

Rediff.com23 Oct 2013

The bank is offering a preferential rate on foreign currency conversion, giving special offers on housing loans and providing assistance for searching properties.

Flipkart, Snapdeal & Uber, watch your ads; big brother is after you

Flipkart, Snapdeal & Uber, watch your ads; big brother is after you

Rediff.com5 Oct 2015

Advertising industry watchdog ASCI upheld complaints against 82 campaigns in June for misleading ads, including those of Flipkart, Uber, Snapdeal, Vodafone.

ASK AJIT: 'How can I make money?'

ASK AJIT: 'How can I make money?'

Rediff.com24 Feb 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.

Secret behind the success of India's stem cell firms

Secret behind the success of India's stem cell firms

Rediff.com6 Jun 2017

Endorsement by celebrities such as Aishwarya Rai, Hrithik Roshan among others and increasing awareness among customers are helping stem cell firms grow the brand footprint

Expert advice: Avoid these stocks and IPOs

Expert advice: Avoid these stocks and IPOs

Rediff.com1 Aug 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Sensex vaults 460 points as prospects of Fed rate hike wane

Sensex vaults 460 points as prospects of Fed rate hike wane

Rediff.com9 May 2016

Top gainers from the Sensex pack are Asian Paints, Bajaj Auto, ITC, NTPC, L&T and HDFC, all up 2% each

'Global correction a big threat to Indian markets'

'Global correction a big threat to Indian markets'

Rediff.com13 Jun 2016

'The recent US jobs report has eased fears of a hike in the Fed meeting.'